Amgen Gives Greater Los Angeles Community an Experience to Remember at FIFA Fan Festival - Amgen
Amgen Gives Greater Los Angeles Community an Experience to Remember at FIFA Fan Festival Amgen
Amgen Company News
What If Amgen Stock's Patent Worries Are Hiding Its Real Growth Engine? - Yahoo Finance
What If Amgen Stock's Patent Worries Are Hiding Its Real Growth Engine? Yahoo Finance
Amgen loses in Harbour antibody patent case, ordered to pay $20M+ - Fierce Biotech
Amgen loses in Harbour antibody patent case, ordered to pay $20M+ Fierce Biotech
AMGEN TO PRESENT AT THE GOLDMAN SACHS 47TH ANNUAL GLOBAL HEALTHCARE CONFERENCE - Amgen
AMGEN TO PRESENT AT THE GOLDMAN SACHS 47TH ANNUAL GLOBAL HEALTHCARE CONFERENCE Amgen
AMGEN ANNOUNCES ADDITIONAL $300 MILLION U.S. MANUFACTURING INVESTMENT, TOTALING NEARLY $2 BILLION OVER THE LAST YEAR - Amgen
AMGEN ANNOUNCES ADDITIONAL $300 MILLION U.S. MANUFACTURING INVESTMENT, TOTALING NEARLY $2 BILLION OVER THE LAST YEAR Amgen
Amgen's Diversified Business, Emerging Pipeline Drives Positive View, RBC Says - 富途牛牛
Amgen's Diversified Business, Emerging Pipeline Drives Positive View, RBC Says 富途牛牛
Amgen owes $20.2 million in antibody patent lawsuit, US jury says - Reuters
Amgen owes $20.2 million in antibody patent lawsuit, US jury says Reuters
Amgen Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Amgen Inc. stock underperforms Wednesday when compared to competitors MarketWatch
An Important Update Regarding TAVNEOS® (avacopan) - Amgen
An Important Update Regarding TAVNEOS® (avacopan) Amgen
Fierce Biotech Layoff Tracker 2026: enGene halves workforce; Neumora cuts 35% - Fierce Biotech
Fierce Biotech Layoff Tracker 2026: enGene halves workforce; Neumora cuts 35% Fierce Biotech
Amgen CEO Bob Bradway's 2025 Letter to Shareholders - Amgen
Amgen CEO Bob Bradway's 2025 Letter to Shareholders Amgen
Amgen Presents 2nd Community Day as L.A. Builds Momentum for Kick Off of FIFA World Cup 2026 - Amgen
Amgen Presents 2nd Community Day as L.A. Builds Momentum for Kick Off of FIFA World Cup 2026 Amgen
Amgen Named One of Newsweek’s Most Trustworthy Companies in America 2026 - Amgen
Amgen Named One of Newsweek’s Most Trustworthy Companies in America 2026 Amgen
Amgen Named One of the 2026 World’s Most Ethical Companies® by Ethisphere - Amgen
Amgen Named One of the 2026 World’s Most Ethical Companies® by Ethisphere Amgen
Amgen (AMGN): Company Profile, Stock Price, News, Rankings - Fortune
Amgen (AMGN): Company Profile, Stock Price, News, Rankings Fortune
FDA hearing on Amgen's Tavneos will include findings from an independent review - Fierce Pharma
FDA hearing on Amgen's Tavneos will include findings from an independent review Fierce Pharma
AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE - Amgen
AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE Amgen
Internal documents reveal: Denmark sues Amgen for millions following MFN exit - medwatch.com
Internal documents reveal: Denmark sues Amgen for millions following MFN exit medwatch.com
Is Amgen Inc. (AMGN) A Good Stock To Buy Now? - Yahoo Finance
Is Amgen Inc. (AMGN) A Good Stock To Buy Now? Yahoo Finance
Amgen Stock’s Gross Margin Story in Q1 2026: What the Numbers Say About a $468 Target - TIKR.com
Amgen Stock’s Gross Margin Story in Q1 2026: What the Numbers Say About a $468 Target TIKR.com
Amgen Named to Forbes’ 2026 List of America’s Best Large Employers - Amgen
Amgen Named to Forbes’ 2026 List of America’s Best Large Employers Amgen
Here’s Why Amgen (AMGN) is Among the 7 Best Longevity Stocks to Buy Now - Yahoo Finance
Here’s Why Amgen (AMGN) is Among the 7 Best Longevity Stocks to Buy Now Yahoo Finance
Highlights from Amgen's 2025 Fourth Quarter and Full Year Earnings Report - Amgen
Highlights from Amgen's 2025 Fourth Quarter and Full Year Earnings Report Amgen
2025 at Amgen: Investing, Expanding, and Serving More Patients - Amgen
2025 at Amgen: Investing, Expanding, and Serving More Patients Amgen
AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS - Amgen
AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS Amgen
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know Yahoo Finance
Highlights from Amgen's 2026 First Quarter Earnings Report - Amgen
Highlights from Amgen's 2026 First Quarter Earnings Report Amgen
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know Yahoo Finance
Amgen (AMGN) Stock Valuation Looks Split Between Analyst Targets And DCF Upside - simplywall.st
Amgen (AMGN) Stock Valuation Looks Split Between Analyst Targets And DCF Upside simplywall.st
AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE - Amgen
AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE Amgen
Healthcare of Ontario Pension Plan Trust Fund Sells 64,867 Shares of Amgen Inc. $AMGN - MarketBeat
Healthcare of Ontario Pension Plan Trust Fund Sells 64,867 Shares of Amgen Inc. $AMGN MarketBeat
FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS - Amgen
FDA APPROVES UPLIZNA® FOR ADULTS WITH GENERALIZED MYASTHENIA GRAVIS Amgen
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA® IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE - Amgen
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA® IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE Amgen
Anjali Rao Joins Amgen India as Executive Director – Human Resources - hrtoday.in
Anjali Rao Joins Amgen India as Executive Director – Human Resources hrtoday.in
Amgen Breaks Ground on $600 Million Center for Science and Innovation in Thousand Oaks, Calif. - Amgen
Amgen Breaks Ground on $600 Million Center for Science and Innovation in Thousand Oaks, Calif. Amgen
AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S. - Amgen
AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S. Amgen
Amgen Once Again Recognized as Top Pharma Company by U.S. Patients - Amgen
Amgen Once Again Recognized as Top Pharma Company by U.S. Patients Amgen
Amgen (AMGN) Stock After Horizon Deal And Strong Multi‑Year Gains Is Price Still Reasonable - simplywall.st
Amgen (AMGN) Stock After Horizon Deal And Strong Multi‑Year Gains Is Price Still Reasonable simplywall.st
Amgen Inc. (AMGN) Announces EC’s Grant of Marketing Authorization for IMDYLLTRA® - Yahoo Finance
Amgen Inc. (AMGN) Announces EC’s Grant of Marketing Authorization for IMDYLLTRA® Yahoo Finance
/C O R R E C T I O N -- Amgen/ - PR Newswire
/C O R R E C T I O N -- Amgen/ PR Newswire